What is ArborGen?
ArborGen is a leader in providing advanced genetics for pine and hardwood seedlings, catering to landowners, forestry consultants, and carbon project developers. Their scientifically developed products are engineered for accelerated growth, enhanced returns, and superior flexibility, crucial for both timber production and carbon sequestration initiatives. By focusing on improved disease resistance and long-term value, ArborGen empowers clients to maximize land potential and navigate the complexities of timber markets and evolving carbon economies.
How much funding has ArborGen raised?
ArborGen has raised a total of $4M across 2 funding rounds:
Debt
$2M
Debt
$1.9M
Debt (2020): $2M with participation from PPP
Debt (2021): $2M led by PPP
Key Investors in ArborGen
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for ArborGen?
The recent major strategic investment signals a strong validation of ArborGen's business model and its contribution to sustainable forestry and carbon markets. This capital infusion is expected to fuel further research and development in advanced tree genetics, expand operational capacity to meet growing demand, and potentially broaden market reach into new geographical regions or client segments. ArborGen is strategically positioned to capitalize on the increasing global emphasis on reforestation, sustainable timber sourcing, and carbon offset projects, leveraging its genetic innovations to drive growth and environmental impact.
See full ArborGen company page
